(Yicai) Feb. 25 -- Shares in Frontier Biotechnologies slumped today, erasing yesterday’s substantial rally, after the Chinese drugmaker said it has granted British pharmaceutical giant Glaxosmithkline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results